Skip to main content

Advertisement

Log in

ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

There are controversial results related to the contribution of insertion (I)/deletion (D) polymorphism of the angiotensin I-converting enzyme (ACE) in the development of diabetic nephropathy. To assess the distribution of this polymorphism in diabetic patients with and without nephropathy we studied 140 unrelated type 2 diabetic patients from the Kermanshah Province of Iran with ethnic background of Kurds including 68 patients with macroalbuminuria and 72 normoalbuinuric diabetic patients as controls. Genotyping was done by polymerase chain reaction (PCR). The frequency of D allele in nephropathic and normoalbuminuric patients were 69.1 and 58.3%, respectively (P = 0.061). In individuals with DD genotype the risk of macroalbuminuria increased 2.87-fold (P = 0.057). Significant lower level of serum ACE activity was found in the normoalbuminuric (59.76 IU/l) compared to macroalbuminuric (97.43 IU/l) patients. The serum ACE activity was significantly higher in macroalbuminuric patients with ID (105.7 IU/l) and ID + DD (100.7 IU/l) genotypes compared to normoalbuminuric patients with the same genotypes (63.5 and 64.2 IU/l, respectively). Treatment with captopril significantly (P = 0.045) reduced the serum ACE activity in normoalbuminuric patients with DD genotype compared to macroalbuminuric patients with the same genotype (33.6 vs. 73.8 IU/l). However, the greatest benefit effect of losartan therapy on ACE activity was observed only in macroalbuminuric patients with DD genotype compared to that in normoalbuminuric patients (61.0 vs. 109.0 IU/l, P = 0.06). Our study suggests the importance of ethnic origin in the development of diabetic nephropathy and demonstrates different responses to therapy according to genotype and stage of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vaisi-Raygani A, Rahimi Z, Nomani H et al (2007) The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem 40:1150–1156

    Article  CAS  PubMed  Google Scholar 

  2. Hadjadj S, Fumeron F, Roussel R et al (2008) Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects. Diabetes Care 31:1847–1852

    Article  CAS  PubMed  Google Scholar 

  3. Jacobsen PK (2005) Preventing end stage renal disease in diabetic patients: genetic aspect (part I). J Renin Angiotensin Aldosterone Syst 6:1–14

    Article  CAS  PubMed  Google Scholar 

  4. Arfa I, Abid A, Nouira S et al (2008) Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 9:32–36

    Article  CAS  PubMed  Google Scholar 

  5. Ruggenenti P, Bettinaglio P, Pinares F et al (2008) Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 3:1511–1525

    Article  PubMed  Google Scholar 

  6. Movva S, Alluri RV, Komandur S et al (2007) Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 21:237–241

    Article  PubMed  Google Scholar 

  7. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR et al (2008) Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J 49:571–576

    CAS  PubMed  Google Scholar 

  8. Rahimi Z, Merat A, Gerard N et al (2006) Implications of the genetic epidemiology of globin haplotypes linked to the sickle gene in Southern Iran. Hum Biol 78:719–731

    Article  PubMed  Google Scholar 

  9. Nikzamir A, Nakhjavani M, Esteghamati A et al (2008) Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition. Nephrol Dial Transplant 23:1274–1277

    Article  CAS  PubMed  Google Scholar 

  10. Nikzamir A, Esteghamati A, Feghhi M et al (2009) The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes. J Renin Angiotensin Aldosterone Syst 10:109–114

    Article  CAS  PubMed  Google Scholar 

  11. American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27:S79–S83

    Article  Google Scholar 

  12. WHO Study Group Report of a WHO consultation: Part 1 (1999) Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva

    Google Scholar 

  13. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hemotology. Vol 6. The thalassemias. Livingstone, UK, pp 74–101

    Google Scholar 

  14. Nakhjavani M, Esfahnian F, Jahanshahi A et al (2007) The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes. Nephrol Dial Transplant 22:2549–2553

    Article  CAS  PubMed  Google Scholar 

  15. Maguire GA, Price CP (1985) A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum. Ann Clin Biochem 22:204–210

    CAS  PubMed  Google Scholar 

  16. Kumar A, Mohindru K, Sehajpal PK (2005) Angiotensin-I converting enzyme polymorphism and diabetic nephropathy in North India. In J Hum Genet 5:279–283

    CAS  Google Scholar 

  17. Tang FY, Liu FY, Xie XW (2008) Association of angiotensin converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem 319:33–39

    Article  CAS  PubMed  Google Scholar 

  18. Ng DPK, Tai BC, Koh D et al (2005) Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14727 subjects. Diabetologica 14:1008–1016

    Article  Google Scholar 

  19. Eleni S, Dimitrios K, Vaya P et al (2008) Angiotensin-I converting enzyme gene and I/D polymorphism distribution in the Greek population and a comparison with other European populations. J Genetics 87:91–93

    Article  CAS  Google Scholar 

  20. Zhou JB, Yang JK, Lu JK et al (2010) Angiotensin-converting gene polymorphism is associated with type 2 diabetes: a meta-analysis. Mol Biol Rep 37:67–73

    Article  PubMed  Google Scholar 

  21. Parving HH, de Zeeuw D, Cooper ME et al (2008) ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. J Am Soc Nephrol 19:771–779

    Article  CAS  PubMed  Google Scholar 

  22. Ha SK, Yong Lee S, Su Park H et al (2000) ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant 15:1617–1623

    Article  CAS  PubMed  Google Scholar 

  23. So WY, Ma RC, Ozaki R et al (2006) Angiotensin-converting enzyme (ACE) inhibition in type 2 diabetic patients: interaction with ACE insertion/deletion polymorphism. Kidney Int 69:1438–1443

    CAS  PubMed  Google Scholar 

  24. Kalaitzidis R, Bakris GL (2009) Effects of angiotensin II receptor blockers on diabetic nephropathy. J Hypertension 27(Suppl 5):S15–S21

    Article  CAS  Google Scholar 

  25. Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotaabed A (2010) Butyrylcholinesterase K variant and the APOE-epsilon4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol Biol Rep 37:2083–2091

    Article  CAS  PubMed  Google Scholar 

  26. Zoppini G, Targher G, Chonchol M et al (2009) Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutr Metab Cardiovas 19:580–586

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This work was financially supported by a grant from Vice Chancellor for Research of Kermanshah University of Medical Sciences, Kermanshah, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zohreh Rahimi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felehgari, V., Rahimi, Z., Mozafari, H. et al. ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem 346, 23–30 (2011). https://doi.org/10.1007/s11010-010-0587-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0587-2

Keywords

Navigation